US2012077246A1PendingUtilityA1
Methods and Devices for Capturing Circulating Tumor Cells
Est. expiryApr 24, 2029(~2.8 yrs left)· nominal 20-yr term from priority
G01N 33/575
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of capturing a Circulating Tumor Cell (CTC) from a sample includes introducing a sample into a microfluidic device having a cell capture surface and a flow modification surface under conditions that allow a CTC to bind to a cell rolling-inducing agent and a capturing agent disposed on the cell capture surface. The flow modification surface induces a rotational flow within the sample as it flows through the microfluidic device.
Claims
exact text as granted — not AI-modified1 . A method of capturing a Circulating Tumor Cell (CTC) from a sample comprising the step of introducing said sample into a microfluidic device under conditions that allow a CTC to bind to a cell rolling-inducing agent and a capturing agent, the device inducing a rotational flow with the sample, the device comprising an immobilized cell rolling-inducing agent and an immobilized capturing agent.
2 . The method of claim 1 further comprising applying a shear stress between 0.05 and 10 dyn/cm 2 on the sample introduced into the device.
3 . The method of claim 2 wherein the shear stress is between 0.1 and 2.0 dyn/cm 2 .
4 . The method of claim 3 wherein the shear stress is about 0.16 dyn/cm 2 .
5 . The method of claim 1 wherein the cell rolling-inducing agent is a selectin or a CTC binding fragment of a selectin.
6 . The method of claim 5 wherein the selectin is selected from the group consisting of E-selectin, P-selectin, and L-selectin.
7 . The method of claim 1 wherein the capturing agent specifically binds a moiety on a CTC cell surface, the capturing agent selected from the group consisting of an antibody, an antibody fragment, an engineered antibody, folic acid, transferrin, a peptide, and an aptamer.
8 . The method of claim 7 wherein the antibody is anti-EpCAM.
9 . The method of claim 7 wherein the peptide is an RGD peptide.
10 - 22 . (canceled)
23 . A microfluidic device for capturing a Circulating Tumor Cell (CTC) from a sample, comprising:
a channel comprising a cell capture surface and a flow modification surface, wherein the cell capture surface comprises a cell rolling-inducing agent and a capturing agent immobilized on the cell capture surface, and the flow modification surface comprises one or more ridges extending into the channel and arranged to induce a rotational flow in a sample flowing through the channel.
24 . The device of claim 23 , wherein the cell rolling-inducing agent is a selectin or a CTC binding fragment of a selectin.
25 . The device of claim 24 , wherein the selectin is selected from the group consisting of E-selectin, P-selectin, and L-selectin.
26 . The device of claim 23 , wherein the capturing agent is adapted to specifically bind to a moiety on a CTC cell surface, and the capture agent is selected from the group consisting of an antibody, an antibody fragment, an engineered antibody, folic acid, transferrin, a peptide, and an aptamer.
27 . The device of claim 26 , wherein the antibody is anti-EpCAM.
28 . The device of claim 26 wherein the peptide is an RGD peptide.
29 . The device of claim 23 , wherein the capturing agent is immobilized on the cell capture surface by direct attachment of the capturing agent to the cell capture surface.
30 - 56 . (canceled)Join the waitlist — get patent alerts
Track US2012077246A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.